Diabetes
-
MiniMed submits new patch pump for FDA clearance
The diabetes tech firm is preparing for the launch of new devices, including a tubeless insulin pump and a fully closed loop automated insulin delivery system.
By Elise Reuter • Sept. 1, 2026 -
Dexcom, Abbott await Medicare coverage expansion for CGMs
Dexcom CEO Jake Leach said he is watching for a decision by the federal health insurance program before the end of the year.
By Elise Reuter • Aug. 27, 2026 -
Explore the Trendline➔
Courtesy of Johnson & Johnson
TrendlineNew medical devices are reshaping the medtech industry
From pulsed field ablation devices to glucose sensors and surgical robotics, new medical technologies are transforming patient care and how people manage their health.
By MedTech Dive staff -
Abbott receives FDA nod for dual-analyte sensor
Abbott plans to roll out the device, called Libre Duo 10 Day, later this year. The sensor can measure both glucose and ketones.
By Elise Reuter • Aug. 25, 2026 -
MiniMed starts shipping new insulin pump with Abbott-made sensor
The company has begun a major marketing campaign to support the launch of its MiniMed Flex insulin pump.
By Nick Paul Taylor • Aug. 24, 2026 -
Deep Dive
5 questions on Abbott’s glucose-ketone sensors
As Abbott prepares to launch its first dual-analyte sensor, endocrinologists talked to MedTech Dive about considerations for continuous ketone monitoring.
By Elise Reuter • Aug. 19, 2026 -
Q&A
Inside Senseonics’ commercial overhaul and what’s next
The diabetes tech firm recently brought its sales and marketing teams in-house after taking over commercialization of its device from Ascensia Diabetes Care.
By Elise Reuter • Aug. 13, 2026 -
Abbott, Google to combine glucose data with AI coaching
The multiyear partnership will connect Abbott’s over-the-counter Lingo sensor and the Google Health app.
By Elise Reuter • Aug. 12, 2026 -
FDA names Dexcom as first participant in digital health pilot
Selected devices will be exempt from certain premarket requirements while manufacturers collect real-world data through Medicare.
By Elise Reuter • July 23, 2026 -
Insulet launches Omnipod 5 in Spain
A high rate of continuous glucose monitor adoption and low level of automated insulin delivery system penetration make Spain an attractive market for Insulet.
By Nick Paul Taylor • July 7, 2026 -
MiniMed launches Abbott-made Instinct glucose sensor in Europe
Overseas markets are central to MiniMed’s business, accounting for 70% of reported net sales in the company’s 2026 financial year.
By Nick Paul Taylor • June 24, 2026 -
Insulet hires first chief R&D officer amid growing competition
Divakar Ramakrishnan brings experience from Convatec and Eli Lilly. Insulet said the new hire was an important step in strengthening the company’s innovation capabilities.
By Elise Reuter • June 23, 2026 -
4 diabetes tech execs on the future of multi-analyte glucose sensors
Executives with Abbott, PercuSense and Biolinq spoke with MedTech Dive about what’s next with multi-analyte sensor technology.
By Elise Reuter • June 22, 2026 -
In a first, Dexcom’s OTC glucose sensor is cleared for kids
The Stelo over-the-counter glucose monitor can now be used by children as young as two years.
By Elise Reuter • June 15, 2026 -
Top medtech stories from ADA’s Scientific Sessions
Dexcom, Abbott, MiniMed and Insulet featured upcoming technologies at the American Diabetes Association’s annual event. Catch up on news coming out of the conference.
By Elise Reuter • June 12, 2026 -
Why Insulet thinks its fully closed loop system will stand apart from rivals
Chief Medical Officer Trang Ly said the system, which allows people to manage Type 2 diabetes without bolusing, will be “completely different” than those being developed by MiniMed and Tandem Diabetes Care.
By Elise Reuter • June 11, 2026 -
MiniMed is in the lead as diabetes tech firms focus on ‘fully closed loop’ systems, exec says
Ali Dianaty, MiniMed’s chief product and technology officer, believes the company is “clearly ahead” of the competition in developing automated insulin delivery systems that don’t require meal announcements.
By Elise Reuter • June 9, 2026 -
Dexcom bolsters evidence for glucose sensors for Type 2 diabetes
New study results could lead to better insurance coverage of the devices for people who don’t take insulin, a researcher said.
By Elise Reuter • June 9, 2026 -
3 takeaways from ADA
Tandem Diabetes Care, Insulet and Dexcom all presented data over the weekend at the American Diabetes Association’s Scientific Sessions.
By Elise Reuter • June 8, 2026 -
Dexcom buys Nutrisense; Insulet rolls out patch pump update
In the lead-up to the American Diabetes Association’s Scientific Sessions, Dexcom announced an acquisition and Insulet improved the software for its latest patch pump.
By Elise Reuter • June 5, 2026 -
Deep Dive
Diabetes tech companies are racing toward ‘fully closed loop’ devices. But automation comes with trade-offs.
Insulet, MiniMed and Tandem Diabetes Care are all working on systems to take meal announcements out of diabetes management.
By Elise Reuter • June 4, 2026 -
MiniMed expands Abbott partnership to add dual glucose-ketone sensor
In its first earnings call, the newly independent diabetes tech firm said it was transforming its product portfolio, with plans that include a patch pump and an algorithm that doesn’t require meal announcements.
By Elise Reuter • June 3, 2026 -
Court overturns Insulet’s $59M trade secret verdict against EOFlow
The U.S. appeals court ruled that Insulet filed the lawsuit too late, considering when it should have learned of the trade secret concerns.
By Nick Paul Taylor • June 1, 2026 -
Abbott receives CE mark for dual glucose-ketone sensor
Abbott’s first dual-analyte sensor comes as competitors are working to develop their own versions of the technology.
By Elise Reuter • May 27, 2026 -
Insulet recalls 7M patch pumps due to leak risk
The recall is Insulet’s second this year related to tears in the device tubing. So far, 24 serious adverse events have been reported.
By Elise Reuter • May 27, 2026 -
Dexcom warns of scrapped glucose sensors being resold
Dexcom has identified two lots of G7 sensors that have been stolen, sold and used by customers.
By Elise Reuter • Updated May 27, 2026